OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-09-01-accounts

Peaches Womb Cancer Trust Annual Report and Accounts 2022-2023

Registered Charity Number: 1190440

1

Table of Contents

Trustees’ Report 2022-2023 .................................................................................................... 3 Achievements this year ........................................................................................................... 3 Patient Support ................................................................................................................................ 3 Raising Awareness ........................................................................................................................... 5 Peaches Patient Voices ..................................................................................................................... 5 Advocating for those affected by womb cancer ................................................................................ 7 Awards ............................................................................................................................................ 8 Fundraising events ........................................................................................................................... 8 Community Fundraising ................................................................................................................... 8 In memory ........................................................................................................................................ 8 A huge thank you ............................................................................................................................. 8 Structure, Governance and Management .............................................................................. 10 Charitable Objects .......................................................................................................................... 10 Management Structure .................................................................................................................. 10 Financial Statement .............................................................................................................. 15 Independent Examiner’s Report ............................................................................................ 19 Financial Review ................................................................................................................... 20 Risk Management ................................................................................................................. 20 Plans for 2023-2024 .............................................................................................................. 21 Patient Support .............................................................................................................................. 21 Raising Awareness ......................................................................................................................... 21 Advocacy ....................................................................................................................................... 21 Promoting Research ....................................................................................................................... 21 Peaches Patient Voices ................................................................................................................... 22 Organisation .................................................................................................................................. 22 Reference and Administrative Details: Acknowledgements ................................................... 23

2

Trustees’ Report 2022-2023

In early 2020, a group of doctors from Saint Mary’s Hospital in Manchester, all with a special interest in womb cancer and research realised that there was no charity dedicated to those affected by womb cancer. They identified that there was a great unmet need. Womb cancer is the fourth most common cancer in women, affecting nearly 10,000 women every year in the UK and the numbers are rising. However, very few people have heard of womb cancer or know what it is. Additionally, research into womb cancer has long been under-funded compared to other gynaecological cancers such as ovarian and cervical, despite it being more common.

In September 2020, Peaches Womb Cancer Trust was established by Professor Emma Crosbie, Dr Eleanor Jones, Dr Chloe Barr, Dr Helen Clarke, Dr Helena O’Flynn and Mrs Rosemary Pike. Its aim is to improve the lives of those affected by womb cancer by raising awareness, support patients and promote and fund research. The name comes from the peach-coloured ribbon that represents womb cancer and was inspired by the fact that a group of survivors refer to themselves as “Peach Sisters”.

This is our third annual report, and what a fantastic year Peaches Womb Cancer Trust has had. We have kept up the momentum we gained in our first two years, and we have increased all our charitable activities, supporting patients, raising awareness, advocating for patients and funding and promoting research. We have been innovative, creative and flexible in order to raise our profile, our funds and to fulfil our charitable aims to help those with womb cancer.

Achievements this year

Patient Support

This year we have continued to keep our website updated with reliable information for patients. Our social media channels update our supporters on events that we are hosting. We continue to host our monthly coffee morning on the first Wednesday of every month. Living with womb cancer can be a lonely place, as those affected rarely get to meet others like them. Our Coffee Mornings aim to provide a safe space for those affected to meet others with similar experiences, to talk, listen, share stories and tips. Since they launched, The Coffee Mornings have gone from strength to strength, often fully and sometimes oversubscribed. Each meeting is different and is driven by the attendees and the items they would like to discuss. This provides interesting, supportive and varied discussions at each meeting. These are facilitated by Anne Lowry (Clinical Nurse Specialist and volunteer), who continues to create a warm and welcoming environment for the meetings. We are thankful for her support and expertise.

3

In September 2022, we hosted our second “Living Well after Womb Cancer” afternoon. This virtual event featured talks from experts in HRT, psychological support, lymphoedema, movement, sexual function, and an update on Peaches Patient Voices. The event was the second of its kind and attendance increased this year. We hope that it gave those who have had or are currently receiving treatment up-to-date and expert advice on recovery and wellness that will help them in their journey. We recorded all the sessions and were able to host four of them on our YouTube channel with permission from the speakers.

In November 2022, we hosted a webinar on “Womb cancer genomics: Research and patient benefit” led by Dr David Church and Dr Neil Ryan. With 130 sign-ups, it was well received and generated some useful feedback. This highlights that our community are interested in hearing about advances in womb cancer research.

In December 2022, we hosted a workshop on “Improving your Recovery – Essential Core and Pelvic Floor. We collaborated with a specialist in exercise after abdominal surgery. This was an interactive workshop where people were able to join in and do the exercises while learning about the benefits. We had 36 sign-ups for this workshop.

In January 2023, we hosted a webinar on “Menopause and Womb Cancer”. Sixty-four people signed up and over half attended the event. This was another interactive workshop where sharing and participation was encouraged. Hosted by Dr Helena O’Flynn and Dani Binnington, they explored the idea of medical and holistic options to manage menopause and its symptoms. We hear this subject mentioned a lot in the Coffee Mornings and we know that it can be a big factor in the recovery of those who are diagnosed with womb cancer.

On the back of our successful webinars, we explored how we could support and help more people diagnosed with womb cancer at the time they need it. We decided to create a bank of short, easily digestible videos, to provide information to people at any point along their womb cancer journey. It can be hard to understand information in the clinical setting, and, for some, questions may come to them once they are in the comfort of their own homes. These videos will be focused on providing medical facts whilst sharing the patient experience. Collaboration with Patient Voices members and Coffee Morning attendees was crucial in directing the content of these videos. We are still in the process of creating the videos and they are due to be completed by mid-2024. Feedback from the volunteers involved in this project has been positive and their willingness to help others feel more informed has been incredible. We are hugely grateful to GSK for providing a grant to fund this project.

4

Raising Awareness

We have been busy making plans for an awareness campaign, in collaboration with The Eve Appeal and GSK, to be launched in September 2023. We ran a YouGov survey to explore awareness of womb cancer and its signs and symptoms. The results showed that 1 in 3 people were not aware of womb cancer and over half were not aware of the most common symptom of the disease (post-menopausal bleeding). We look forward to seeing the impact of this awareness campaign and will report on this in our next annual report.

Our social media channels are being used to inform people of our events, to thank and celebrate the success of our fundraisers, and to share information about womb cancer. We are delighted to be seeing an increase in followers and activity on these pages.

We collaborated with a freelance designer to create a suite of social media tiles and to create a signs and symptoms poster that we can share with our supporters to help raise awareness. This work has also helped to refine the look and feel of our public facing content.

The International Gynecological Cancer Society approached us to support their international campaign to advocate for June to become Uterine (Womb) Cancer Awareness Month. This campaign was supported by 25 partners across 34 countries and translated into 11 languages. We were proud to support this campaign and will be taking the learnings from this into our own work as well as supporting the wider campaign again next year.

Trustees have participated in events raising awareness including Helen White attending Whittington golf club to speak at their fundraising event and Helena O’Flynn at Fulshaw WI.

Anne and Helen White participated in a UK Cancer Genetics Group/ CanGene-CanVar/ Association of Genetic Nurses and Counsellors Consensus Meeting, the aim of which was to make recommendations for the design of a patient information leaflet for cancer susceptibility genetics conditions, using Lynch syndrome as an exemplar. We hope that Peaches will be involved in codesigning the resultant leaflet for Lynch syndrome as this genetic condition causes approximately 3% of all womb cancers, and that Peaches will be co-badged on the leaflet subject to review and approval.

Promoting research

Peaches Patient Voices

Peaches Patient Voices (PPV) has continued to facilitate connections between people affected by womb cancer and researchers to ensure that womb cancer research addresses what matters most to patients and their families, ultimately improving outcomes for those living with and beyond womb cancer.

5

Membership of PPV increased by 28% over the course of the year, from 60 to 77 people, all of whom have experienced womb cancer themselves or have cared for someone diagnosed with womb cancer. Through PPV, a wide range of womb cancer research projects have been shaped by its members, including:

Moreover, Helen White, who leads PPV, was invited to join the Refining Adjuvant treatment IN endometrial cancer Based On molecular features (RAINBO) Advisory Committee and to be a coapplicant on the RAINBO No Specific Molecular Profile (NSMP) ORANGE trial. Helen was also invited as one of four patient advocates from around the world to contribute to the Gynaecological Cancer International Group Endometrial Cancer Consensus Conference on Clinical Research to be held in November 2023.

As well as promoting involvement in research, PPV has disseminated opportunities for its members to participate in research, for example, by completing surveys or attending workshops, and some of its members reviewed a guide to Lynch syndrome produced by the Eve Appeal. Furthermore, two members of PPV volunteered to share their experience of womb cancer, one at a Wellbeing of Women webinar titled, “Let’s Talk Gynae Cancers”, and another at a workshop for a pharmaceutical company’s employees. PPV members’ contributions have also been instrumental in shaping Peaches' input to NICE appraisals of novel womb cancer treatments, as well as co-producing a series of videos to help Peaches improve support for those affected by womb cancer, to be launched in 2024.

PPV was delighted to host its inaugural research webinar, “Womb cancer genomics: Research and patient benefit,” in November. We are very grateful to Dr David Church and Dr Neil Ryan for giving such informative and engaging talks which were extremely well received by those who attended. Dr Ryan’s talk has proven to be the most watched on our YouTube channel as of August 2023.

Following on from last year’s success in the University of Manchester’s Social Responsibility in Biology, Medicine and Health Public Patient Involvement and Engagement (PPIE) Awards, we were invited to contribute to a blog series featuring the award recipients, which can be accessed here:

6

https://blogs.manchester.ac.uk/bmh-sr/2023/05/22/ppie-award-winner-helen-white/

Advocating for those affected by womb cancer

Having been invited last year to contribute to both the Scottish Medicines Consortium (SMC) and National Institute of Health and Care Excellence (NICE) appraisals of pembrolizumab with lenvatinib for second line treatment of advanced and recurrent womb cancer, we were delighted to hear in October that the SMC had approved this drug combination for use by NHS Scotland.

However, NICE’s initial decision not to recommend this treatment prompted a period of consultation during which our incredible community rallied to provide new evidence that helped us shape our response. We were therefore thrilled with the news in May that NICE’s final decision was to recommend this treatment, ensuring for the first time in decades that a more effective second line treatment was available to all patients with advanced and recurrent womb cancer across the UK. This would not have been possible without the contributions of Peaches Patient Voices and members of the Womb Cancer Support UK community, whose powerful testimonies and experiences informed our submissions to the appraisal process.

Our press release on this news was picked up by several social media news outlets including BBC News, Sky News and The Independent, as well as in print in the Daily Express. We are incredibly grateful to Grace Teeling whose powerful story garnered wide media attention ensuring that this welcome news and coverage of womb cancer potentially reached millions of people across the UK and beyond.

We have been asked this year to contribute to the NICE appraisal of dostarlimab (with carboplatin and paclitaxel) for first line treatment of one type of advanced or recurrent endometrial cancer (mismatch repair deficient) and very much hope that this will be recommended by NICE next year.

In February, we were invited to respond to the Royal College of Obstetricians and Gynaecologists (RCOG) policy position statement on gynaecological cancers. The statement illustrates RCOG’s key recommendations to improve prevention, diagnosis and treatment to the UK government and NHS. We responded regarding the need for increased awareness, noninvasive and appropriate testing, equitable access to testing for Lynch syndrome and adjuvant therapies. The final statement has not yet been published by RCOG.

7

Awards

In May, Eleanor Jones, Chloe Barr, Helena O’Flynn and Helen Clarke were honoured to be awarded first place in the student group category at the University of Manchester Volunteer of the Year Awards. They were recognised for their dedication, passion and drive in setting up and running Peaches Womb Cancer Trust.

Fundraising events

In September we launched our Million Steps fundraising campaign, asking people to take part in a 3-month steps challenge while raising money. It was a fundraising success reaching its target and it certainly got people stepping.

In May we repeated our Peaches and Cream Tea fundraising event. We didn’t have as many people taking part as we had hoped, but our loyal supporters did a great job of raising money while spreading awareness of womb cancer.

Community Fundraising

Community fundraising was a great success this year with people taking part in their own events and choosing to raise money for Peaches. Our supporters ran, swam, cycled, baked, raffled hampers, shaved their heads, played ukelele gigs and completed the world’s toughest obstacle race. In doing so, they raised over half of our income this year. Many of our supporters have direct experience of womb cancer or are friends or family of someone who was diagnosed with womb cancer. The selflessness of this community never ceases to amaze us, and we are forever grateful for all their support.

In memory

Losing a loved one is heartbreaking, and we are grateful to the families who chose to make donations to Peaches from funeral collections and celebration of life events. Our hearts go out to those who have lost their loved ones to womb cancer this year. Our work in raising awareness of this disease will continue thanks to your generous support.

A huge thank you

We could not undertake any of our work without the generous donations and hard work of our supporters. Our fundraisers were creative during the pandemic and have since continued to raise a huge amount of money for Peaches. We would like to say a massive thank you to all who have

8

held fundraising events and activities. Without all your support and you attending our events, we would not be where we are today.

A special thank you must go to all of those who, despite living with or beyond womb cancer, have raised money for us. The efforts, creativity, and drive to continue to raise awareness and funds to help people now and in the future is inspiring.

Finally, thank you to all the Trustees and volunteers who have worked so hard over the last year to grow the charity. Most have done this alongside full-time jobs and the dedication they have shown to the Charity and to the womb cancer cause is inspirational. A special thank you goes to Helen White who has gone over and above her trustee role by leading on PPV and the patient videos project this year. Her attention to detail and drive to make sure that these areas benefit those with womb cancer is inspiring. Dr Helena O’Flynn, Chair of Trustees, and Dr Eleanor Jones, Deputy Chair of Trustees, have been pivotal in the growth of Peaches this year. They have both been very hands on with the day-to-day delivery of our charitable aims, fundamental in delivering our objectives and expanding the team, all while holding down full-time jobs and raising young families.

We are delighted by the success that Peaches Womb Cancer Trust has had in its third year. We are looking forward to growing as a charity and improving the lives of those affected by womb cancer.

9

Structure, Governance and Management

Peaches Womb Cancer Trust is registered with the Charity Commission no: 1190440. It was established on 16[th] July 2020 and officially launched on 1[st] September 2020. This is the third set of accounts the charity has prepared, and this set of accounts covers the period from 1[st] September 2022 to 31[st] August 2023.

Charitable Objects

The objectives, as set out in the governing document are:

“To relieve sickness and to preserve the health and improve the experience of women with or at risk of womb cancer and their families in the United Kingdom, in particular but not exclusively by; carrying out research, raising awareness and the provision of patient education and support services.”

From 1[st] April 2018, the Charities Act requires that all charities ensure they meet their charitable objectives and that these are for the public benefit. The Charity Commission in its “Charities and Public Benefit” Guidance states that there are two key principles that must be met:

  1. There must be an identifiable benefit

  2. The benefit must be for the public or a section of the public.

The Trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake. The Trustees are satisfied that the aims and objectives of the charity and the activities reported on in this Annual Report meet these principles.

Management Structure

The Charity is run by a Board of 8 Trustees, 5 of whom founded Peaches Womb Cancer Trust. They are:

Professor Emma Crosbie, President.

Professor Crosbie is Professor of Gynaecological Oncology at the University of Manchester and consultant gynaecological surgeon at St Mary’s Hospital. Her clinical practice focuses on the fertility-sparing management of endometrial cancer and its precursor lesion, atypical hyperplasia. Her research into the prevention and early detection of womb cancer was recognised through a prestigious National Institute for Health Research (NIHR) Clinician Scientist Fellowship award in 2013 and the Royal College of Obstetricians and Gynaecologists William Blair

10

Bell Memorial Lectureship in 2017. She led the James Lind Womb Cancer Alliance Priority Setting Partnership that identified the top ten most important unanswered research questions in womb cancer, according to patients, carers and healthcare professionals. She is Chair of the Endometrial Subgroup of the National Cancer Research Institute (NCRI) Gynaecology Group, a member of the NCRI Screening, Prevention and Early Diagnosis (SPED) committee, and Early Detection Lead for the Manchester NIHR Biomedical Research Centre. Her research team ‘Team Womb’ won the NCRI Cancer Research Excellence in Surgical Trials (CREST) award in 2019 for outstanding recruitment to surgical trials.

Professor Crosbie is a busy mum of three who leads a diverse team of enthusiastic scientists and doctors who strive to carry out high quality research that improves the care of women affected by womb cancer. #wombwarriors.

Dr Chloe Barr, Trustee

Chloe is a Specialist Registrar in Obstetrics and Gynaecology recently completing a PhD at the University of Manchester investigating novel diagnostic and prognostic biomarkers for gynaecological malignancy. In 2010, she graduated from the University of Liverpool with MBChB honours and commenced the Obstetrics and Gynaecology specialist training programme in 2013. In 2018, she joined the clinical research team at St. Mary’s Hospital Manchester, where, in addition to her research, she worked clinically looking after and treating women with gynaecological cancers. She is now back working clinically and aims to apply for gynaecological cancer surgical training. During her time working for Professor Crosbie, she treated and monitored women with womb cancer who are unable to undergo surgical treatment, either due to fertility reasons or other medical issues. Her experience as a clinician and researcher has made her passionate about improving services for women with womb cancer, including early detection, prevention and personalised treatment. This inspired her to be a part of the founding team of Peaches Womb Cancer Trust, a charity dedicated to raising awareness about womb cancer and funding ground-breaking womb cancer research.

Dr Eleanor Jones, Deputy Chair of Trustees

Eleanor is a Specialist Registrar in Obstetrics and Gynaecology. She has recently completed a PhD at the University of Manchester, investigating the early diagnosis of endometrial cancer and how it can be improved under the supervision of Professor Crosbie. She undertook her medical training at the University of St Andrews (BSc) and then the University of Manchester (MBChB), graduating in 2013. She started specialist training in Obstetrics and Gynaecology in 2015. Eleanor’s long-term aim is to have a career as a Gynaecological Oncologist.

11

Dr Helen Clarke, Trustee

Helen studied medicine at Keele University following completion of an undergraduate BSc in Biomedical Science at De Montfort University, Leicester in 2007. She commenced her specialist training in Obstetrics and Gynaecology in 2014 within the Mersey region. In 2016 she was awarded an £18,000 entry level research scholarship from the Wellbeing of Women for research based at University of Liverpool. In 2022 she completed her PhD at the University of Manchester with Professor Crosbie and Dr Sacha Howell (Christie Hospital, Manchester) developing a clinical trial for cancer prevention in both endometrial and breast cancer, using dietary interventions.

Dr Helena O’Flynn, Chair of Trustees.

Helena is a General Practitioner working in Manchester following the completion of an Academic Clinical Fellowship training programme and a Masters in Public Health. She has an interest in the early detection of gynaecological cancers in Primary Care and women’s health. She graduated from medical school at the University of Manchester and was subsequently awarded an NIHR Doctoral Research Fellowship in 2018 and is undertaking a PhD at the University of Manchester investigating methods of early detection of endometrial cancer as well as awareness of symptoms of endometrial cancer.

Mr Malcolm Pike, Trustee

Malcolm joined the board in September 2022. Malcolm is an employment lawyer, business advisor and non-executive director with over 40 years’ experience in private legal practice. He is currently Chair of Governors at Withington Girls’ School, Vice President and NED of the Greater Manchester Chamber of Commerce, Chair of the Rugby Football League’s Independent Employment Tribunal, a member of the ACAS panel of Independent Arbitrators, and Associate General Counsel – Employment (EMEA) at Associated British Foods plc. Malcolm’s governance, management and legal experience is very beneficial to our Board.

Mr Simon Burrows, Trustee

Simon is a chartered accountant, with over 40 years’ experience of working in business – the last 25 years as a CFO in a range of SMOs. His family have been affected by cancer in the past, and he has 2 daughters, and is therefore very committed to the Charity’s ethos and causes.

He brings with him huge experience in all areas of finance, corporate governance and financial stewardship – and thus is an invaluable point of reference for the Trustees in the financial management of the Peaches.

12

Mrs Helen White, Trustee

Helen was diagnosed with womb cancer in 2017 which she subsequently discovered was due to Lynch syndrome. This lived experience inspired Helen’s keen interest in PPIE and led her to join the Participant Panel at Genomics England, the Patient Reference Panel for CanGene-CanVar, and the NCRI Gynaecological Group. Helen established and runs Peaches Patient Voices, our fantastic group of people with lived experience of womb cancer who want to be involved in shaping womb cancer research. She also provides a unique patient perspective to the Peaches’ team, helping to make sure we stay focused on what matters to those affected.

Employees

Miss Louise Brimble

Louise joined the team in September 2022 as our Fundraising and Operations Manager and our first employee. She comes from a national charity background with a focus on fundraising. She has been instrumental in implementing our systems and processes and setting us up for future growth while delivering what is needed today to support the charity. It is due to this process that we have been able to identify our key areas of growth and are able to expand the team to include a Marketing Manager. Louise has taken the position of CEO from August 2023 and we look forward to seeing what the future brings.

Volunteers

Mrs Anne Lowry

Anne is a Macmillan Gynaecology Clinical Nurse Specialist at St Mary’s Hospital in Manchester. Anne qualified as a nurse and graduated from the University of Northumbria with BSc (Hons) in Nursing Studies in 1997. She has worked within the speciality of gynaecology for most of her career in a variety of roles before becoming a nurse specialist in 2007. This nurse specialist role allows Anne to support women and their families who are affected by gynaecological cancers.

Anne has always had an interest in womb cancer. She completed her MSc in Nursing Studies in 2019 with distinction and focused the modules of this degree towards learning more about the experiences of women with womb cancer and how best to support them. She has also been involved in health promotion events to raise the profile of womb cancer and is very aware through this work that a national charity like Peaches Womb Cancer Trust has a big part to play in improving the outcomes for women with this disease. Anne has set up, nurtured, and grown our Peaches Coffee Mornings and created a mutually supportive environment in them. She has also grown our network of CNS contacts to allow us to reach more patients.

13

Mrs Harriet Hirst

Harriet began her career as a software developer and is currently a Customer Relationship Manager Leader at Heywood Pension Technologies. Harriet has volunteered this year as our website developer, bringing lots of great ideas to the team and she and has done a brilliant job of ensuring that website content is kept up to date.

Dr Madeline Poulton

Madeline is an HR professional with over 20 years’ experience working with regional and global HR teams. She also volunteers for Maternity Action as their HR Volunteer. Madeline joined the Peaches Team in July 2022 and has been pivotal in setting the Charity up as an employer and leading on the recruitment process for our new employee positions within the charity.

Mrs Rosemary Pike.

As one of the founding trustees of Peaches, Rosemary chose to stand down at the end of 2022 and has continued to be a volunteer. Rosemary sends out all promotional material to Nurse Specialists and fundraisers helping them to raise awareness and funds. Rosemary is also a great advocate for Peaches, continuing to hold fundraising events at her home and involving her flower club and the local WI in raising money for Peaches.

14

Financial Statement Peaches Womb Cancer Trust srATEMENT OF FINANCIAL ACTIvrrIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT) FOR THE PERIOD ENDED I SEPTEMBER 2023 Notes Total Funds 2023 Total Funds 2022 INCOMING RESOURCES Intomlng r*sources from 8enèrated funds Donations and legacies Income resources from charitable Ktivities Bank interest 8,412 56.767 350 8,466 24.298 Total Incomlng resour 65,529 32.764 RESOURCES EXPENDED Cost of generatlng fvnds Costs of generating voluntary income Fundraising tradin8'. (Qsts o18ood5 sold Employee costs Charltable alms 2,458 2.447 28,030 3,S48 1,075 S,766 34,037 9,288 NEf INCOMING RESOURCE5 AVALIABLE 31.492 23,476 Governance costs 2,589 1,164 Total ￿SoUrceS expended 36,626 10,451 MOVEMENT IN FUNOS 28.903 22,313 TOTAL FUNDS CARRIED FORWARD 28,￿3 22.313 15

Peaches Womb Cancer Trust BALANCE SHEEr AS AT I SEPTEMBER 2023 2023 2022 Note CURRENT ASs￿s Debtors Cash and bank 66,601 37.697 66.601 37.697 CREDITORS: Amounts due wlthln on• y•af TOTAL ASSETS LESS CURRENT LIABIUTIES 66,601 37.697 THE FUNDS OF THE CHARITY Brou8ht forward lunds 37.697 15,384 Movemenl In year 28.903 22.313 Unre5trlcted funds 66,601 37,697 TOTAL CHARrfY FUP4DS 66,601 37.697 16

Peaches Womb Cancer Trust NOTES TO THE FINANCIAL sfATEMEP FOR THE PERIOD ENOEO I SEPTEMBER 2023 I ACCOU14llNG POLICIES Basfjs of prepa￿tIOn The financial statements of the charity, which 15 a public benefit entrty under FRS 102. have been prepared in CCordar￿e with the Chèrities SORP (FR5 1021'Accountin8aThJ ReportinB by Chartties.. stsiement of recommended Praitice ap￿1[able to charities preparing their accounts in ￿COrdance with the Financial Reportir¥ Standard applKable in the UK and Aepublic of Ireland IFRS 1021 leflective l January 20151,. Finjncial Reportin8Siandard 102'The Financial ReportlnK Standard applicable in the UK and REpUlA￿ ol Ireknd., the Charitie5 Accounts Ikotlarvjl ReÉulatlon5 2￿6 nd the Charities Act 2011. The finarKial ststement5 ha¥Y been prepared undef the historical costconvention. I￿01￿￿ All Incomln8 r•sourc•s are 5nclUd￿ In lh• stat•m•nt of financlal aCt￿lIS wh•n thgcharity is •ntrtlod to the Income and the amount can quantified with reasoTrat4e accuracv. Re$oUr￿ expended Expendlture ha5 been char8ed to the Income andexpendiitsre a(cr￿nton t￿3c(ma1$basls. The Irrecovefable dement of VAT is Included with the item of expensetowhich it retste5. Ch•rltable èxpefylllur¢romwlsesthes¢¢osts Irrtwwl ty the ¢￿rIty in dÈlfv¢ryof Its¥t1￿lI¢S and s¢rYk¢s for Its beneficlarles. It Sncludes both coststhat can ￿ alk<ed dlreaty ro such aalvillesand ih05ec05t5 of an Indlreci nature necessary to support them. Governènce costs irKlude those costsassociated with meetiNd constitutional and stat￿ory requlrements of the charlty and Include the lees and r05ts Ilnked to thestrate8K mana8emenl of thecharity I D014ATIONSAND LEGAaES 2021 2022 Dlrert Dofiations Gift Ald Memory Gl¥ln8 LegKie5 5,927 1,775 709 8.412 2 INCOMING RESOURCE5 FOR CHARfTABLE ACTNrrES 2023 2022 Owned fundraising Community fundraising Corporare fundraising Gran15 and trusts fundraisin8 5hoppSni fundraSslng 6.750 26,033 Z76 23,460 7,733 5,217 1.420 322 24,298 56,767 17

NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED I SEPTEMBER 2023 3 TOTAL RESOURCES EXPENDED Total 2023 Total 2022 Costs of generatln8 funds C05t5 of generating voluntary income Charitable aims Employee costs Total 2,458 3,548 28,030 34,037 2,447 5,766 1,075 9,288 Governance 10st5 Accountancy fees Runnin8 Costs 1,140 1,449 2,589 93 1,071 1.164 36.626 10,451 4 TRUSTEES None of the trustees lor any persons connected with theml recetved any remuneration during the perlod. 5 DÉBTORS 2023 2022 Trade debtor5 6 Creditor5 2023 2022 Accruals 18

Independent Examiner's Report PEACHES WOMB CANCER TRusr INDEPENDEKf EXAMINER5 REPORT TO THE TRusfEES OF PEACHES WOMB CANCER TRUST I rerA)rtto the trLStees on my ex3minatiN Of￿ ￿cr￿S of tharity for year erKkd I Septemter 2023, which are set out w page5 9 to 12. Respethe respoffjlbllltles of trustees •Thl eXn￿n¢T Tt charity's frustees are resronsible for We￿rat￿￿) ¢f aC￿rts In accord)r(e with char￿e5 Ad 2011. Thecharity trLthesccAwderth)ttt rewiremerts {￿tiOn 144ofY char￿e$Att2011 do not aprAy. It L% my respwsibility to.. examirE the accounts urkr section 145 of Chribes Act 2011 to follow the pr(￿edureS laiddown In theqewal DirectkY6 gven ty the Cl¥rity C￿MiSsion under Sects￿ 145lSllbl of the C￿rIt￿ Act 2011 To stste whether parbcular rnatters have come to my attentior Ba51s of Independent•xarnlnerf5 report My examination isorried out in aCcorda￿e with gereral th'reaiors given tr¢ itte Charity C(¥nmissk)n. An eyam5nation irtI￿eS a review of re(ords keLX tharty arnl a ctymDarls(x) ￿ tr accwnrs wesenreo with ￿e rectrds. Italso ir￿1￿Je$ C(m￿tha¢0no1anY unusual iten)sor disdosures In tre accounts and seeks explanatky6 from c(KKemiThJ any s￿h matters. w(edures U￿ertaken do not wovide all the evidwKe tN)t w<KI￿ be requi￿ In an a￿1 cwynljy l express an audit otAniw gwen acc￿5. IndeperKlent exarnlmrfs s13ternent In connethon with rny eKAminabon, rn maiter has come to my attention.. lal Whlch glves me reasorotle cause to telieve that in any materhil respect the retyiremerts.. to keep accountiN records in accorthrKe with seLL¥I 130 of the Charities Act 2011 to prepare accounts WTr￿h acctyd wth tt rec(Yds arwj cOm￿Y with Regulabon 8 C{t￿ ActhJnts Regulati￿6 las ameThJedl requirements the fts-m aTh1 contert of acc(xJnts set Ch)riDes {Accwnts arKI Rektrsl Reg￿ab'or￿ Ctsrths kt 2011; Have not rRen met,. or Ibl To whth, in my orxnkn, attenkn te itrawn In wder to e￿tle a kYOFer uTrrstsndlrvJ of the accwnts to trR reached. Paul Mellor ACA Clarke Nicklin LLP Chartered Accoutrtants Clarke Nlcklln House Ctr*adle Royal Buslness Park Cheadle Cheshire SK8 3fD Dated.. 19IC612024 19

Financial Review

The accounts have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the charity’s governing document, the Charities Act 2011 and the Statement of Recommended Practice, “Accounting and Reporting by Charities”, issued in March 2005.

As shown in the Statement of Accounts, Peaches Womb Cancer Trust’s income for this second year has been predominantly from community fundraising and grants and trusts fundraising. We are very grateful to all of those who chose to donate or fundraise for us and to the organisations who generously gave us grants, particularly GSK, The Basil Samuel Trust, The Albert Hunt Trust and the Marsh Charitable Trust.

For Peaches Womb Cancer Trust to grow and to further its aims and objectives, more manpower in the form of both volunteers and employees is needed. Our primary focus has been to obtain sufficient resources to fund our next employees. Therefore, the bulk of the income we have received has not yet been spent as it is being saved for this purpose. Our secondary financial focus was to fund a patient support project to create information videos, which are currently in development. Thanks to the generous sponsorship of GSK, the cost of the awareness campaign that we are planning in conjunction with The Eve Appeal for September 2023 will not be borne by Peaches Womb Cancer Trust.

Risk Management

The trustees have assessed the major risks to which the charity is exposed and are satisfied that systems are in place to mitigate exposure to the major risks. An up-to-date risk register is maintained and regularly reviewed.

20

Plans for 2023-2024

Patient Support

In the coming year, we will complete the patient support videos and host them on our website and on our YouTube channel. We are planning a major update of the website so that the information it contains is more accessible and digestible. We will continue to develop our patient support services this year, and we will be conducting a survey in the early part of the year to inform us of the most pertinent unmet support needs so that we can look to provide these. We will then develop these services in collaboration with our Patient Voices and Coffee Morning attendees. Additional funding will be applied for to fund this project.

Raising Awareness

We will take the learnings from our national awareness campaign in September 2023 and continue to raise awareness of womb cancer. We will aim to create and run a campaign in June 2024 and champion the newly formed Womb Cancer Awareness Month. We will be focusing on highlighting the signs and symptoms of womb cancer alongside powerful stories of people who have been affected by womb cancer and how early diagnosis saves lives.

Advocacy

“We will continue to advocate for womb cancer patients and their loved ones on a national level to #GiveWombCancerAVoice. We will do everything we can as part of the NICE and SMC appraisal process to ensure that the views of those with experience of womb cancer are counted. We hope that this will increase the likelihood of a positive outcome of these appraisals and approval of these vital new treatments.”

Promoting Research

We will continue to offer research bursaries to early career researchers presenting their work into womb cancer at conferences to support the future of womb cancer research. Our long-term goal is to fund significant research projects with tangible outcomes; however, these are very costly. We plan to start a fund that will grow over the coming years to allow us to do this in the future. We will explore ways to fund entry level research posts and collaborate with other organisations.

21

Peaches Patient Voices

We will continue to grow the Peaches Patient Voices community and its involvement in varied research projects, ensuring that womb cancer research is focused on the needs of the patients.

Organisation

Trustees

Over the coming year we will seek to diversify our Board to bring in a wider skillset and different experiences. We will particularly look for Trustees with marketing and fundraising experience. We hope to expand the Board to support the development of our patient support services focusing on the areas not currently covered including oncology and psychological support.

Volunteers

We know the value of volunteers and are grateful for their support as without them we would not be where we are today. We will look for volunteers with marketing, fundraising or patient support experience.

Employees

We have successfully recruited for and now look forward to welcoming two new employees early in the next financial year. They will be employed as our Marketing Manager and Fundraising Officers. We hope that our new Marketing Manager will help us to expand our reach and the Fundraising Officer will help us to secure new funding streams, allowing the organisation to continue to grow.

22

Reference and Administrative Details: Acknowledgements

Peaches Womb Cancer Trust is an independent charitable Trust.

Registered Charity (England and Wales) no. 1190440.

Our registered address is: Peaches Womb Cancer Trust, Clarke Nicklin House, 4 Brooks Drive, Cheadle Royal Business Park, Cheadle, Cheshire, SK8 3TD

Governing Document

Accountants: Clarke Nicklin Clarke Nicklin House 4 Brooks Drive Cheadle Royal Business Park Cheadle Cheshire SK8 3TD

Solicitors:

Addleshaw Goddard LLP Milton Gate 60 Chiswell Street London EC1Y 4AG

Bankers: CAF Bank 25 Kings Hill Avenue Kings Hill West Malling Kent ME19 4JQ

www.peachestrust.org Email: admin@peachestrust.org

Instagram: @peaches_trust Facebook: Peaches Womb Cancer Trust. Twitter: @peachestrust

23